C12N 2760/16142
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2760/16142 (Virus or viral particle as vehicle) appears on 3 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 11
- Assignees
- 9
- Inventors
- 24
- Latest grant
- 3 Jan 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Virus-like particles co-expressing Toxoplasma gondii IMC, ROP18, and MIC8, and pharmaceutical composition comprising the same3 Jan 2023US 11,542,477 B2Health Park Incorporated
- Vaccine composition and uses thereof14 Jan 2020US 10,532,090 B2Biolife Science QLD Limited
- Splitting GP4118 Feb 2014US 8,652,459 B2Inserm
- Virus-like particle comprising toxoplasma gondii protein and influenza virus protein, and diagnostic method using same14 Mar 2024US 2024/0085420 A1Health Park Incorporated
- Viral mediated gene delivery for transient expression of proteins3 Nov 2022US 2022/0348960 A1
- Virus-like particles co-expressing toxoplasma gondii imc, rop18, and mic8, and pharmaceutical composition comprising the same8 Jul 2021US 2021/0207102 A1Health Park Incorporated
- Methods of improving efficacy of allergy vaccines18 Jun 2020US 2020/0188511 A1Anergis S.A.
- A vaccine composition and uses thereof4 May 2017US 2017/0119867 A1Biolife Science QLD Limited
Most cited
By later US patents